Investigators → Marcus V. Delgado
ORA-SW-DAL · Southwest Division (Dallas District)
Strictness Percentile: 68th
Marcus V. Delgado — FDA Investigator Citation Profile
Focuses heavily on 21 CFR 111.75(a)(1)(i) and 21 CFR 111.205(a). Expect a request for your Approved Supplier List, raw component identity testing chromatograms, and last 24 months of OOS/CAPA logs within the first 2 hours of opening conference.
Top Cited Clauses: 21 CFR 111.75(a)(1)(i), 21 CFR 111.205(a), 21 CFR 117.35(c)
Simulate Inspection by Marcus V. Delgado →
Recent Form 483s Linked to Marcus V. Delgado
Victory Medical Center Pharmacy (2026-09-10) · 2 observations
View 483 →Imprimis NJOF LLC (2026-08-18) · 2 observations
View 483 →Annovex Pharma Inc (2026-07-03) · 2 observations
View 483 →Strides Pharma Science Limited (2026-05-20) · 2 observations
View 483 →Philips Oral Healthcare, LLC (2026-05-08) · 2 observations
View 483 →Zhejiang Huahai Pharmaceutical Co., Ltd. (2026-04-24) · 2 observations
View 483 →Biomat USA Inc (2026-04-14) · 2 observations
View 483 →Q-Med AB (2026-03-27) · 2 observations
View 483 →Dr. J Skinclinic, Inc (2026-03-23) · 2 observations
View 483 →2seventy bio, Inc. (2026-03-20) · 2 observations
View 483 →Viant San Antonio, Inc. (2026-03-19) · 2 observations
View 483 →Kibun Foods Inc. Funabasi Factory (2026-03-13) · 2 observations
View 483 →COSMETIC LABORATORY INC (2026-03-10) · 2 observations
View 483 →Steven M. Wolf, M.D. (2026-03-05) · 2 observations
View 483 →Catholic Health Initiatives Institute for Research and Innovation IRB (2026-03-03) · 2 observations
View 483 →